IN2006CH00859A - - Google Patents
Download PDFInfo
- Publication number
- IN2006CH00859A IN2006CH00859A IN859CH2006A IN2006CH00859A IN 2006CH00859 A IN2006CH00859 A IN 2006CH00859A IN 859CH2006 A IN859CH2006 A IN 859CH2006A IN 2006CH00859 A IN2006CH00859 A IN 2006CH00859A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/127—Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/10—Bacillus licheniformis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/125—Bacillus subtilis ; Hay bacillus; Grass bacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49478603P | 2003-08-14 | 2003-08-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2006CH00859A true IN2006CH00859A (es) | 2007-06-22 |
Family
ID=34215900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN859CH2006 IN2006CH00859A (es) | 2003-08-14 | 2006-03-10 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050271643A1 (es) |
EP (1) | EP1654348A4 (es) |
JP (1) | JP2007518394A (es) |
KR (1) | KR20060056991A (es) |
CN (1) | CN101076585A (es) |
AU (1) | AU2004267383A1 (es) |
BR (1) | BRPI0412978A (es) |
CA (1) | CA2535951A1 (es) |
IL (1) | IL173692A0 (es) |
IN (1) | IN2006CH00859A (es) |
MX (1) | MXPA06001722A (es) |
RU (1) | RU2006107931A (es) |
WO (1) | WO2005019417A2 (es) |
ZA (1) | ZA200601265B (es) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
US8192733B2 (en) * | 2003-08-29 | 2012-06-05 | Cobb & Associates | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
CN100569243C (zh) * | 2004-12-15 | 2009-12-16 | 北京天施康医药科技发展有限公司 | 一种治疗溃疡性结肠炎的凝结芽孢杆菌活菌制剂的制造方法和应用 |
US8414878B2 (en) * | 2005-04-28 | 2013-04-09 | Irina Grigorievna Osipova | Irilis biopreparation based on bacillus-strain bacteria, bacillus subtilis and bacillus licheniformis contained therein |
CN101257804A (zh) * | 2005-05-18 | 2008-09-03 | 帝斯曼知识产权资产管理有限公司 | 用于微生物的肠应用的组合物 |
US20090036849A1 (en) * | 2005-12-22 | 2009-02-05 | Sca Hygiene Products Ab | Absorbent Article |
US20080260906A1 (en) * | 2006-03-17 | 2008-10-23 | Marko Stojanovic | Compositions comprising probiotic and sweetener components |
US20100248369A1 (en) * | 2006-08-21 | 2010-09-30 | Calpis Co., Ltd. | Renal-function-ameliorating agent |
WO2008069102A1 (ja) * | 2006-12-06 | 2008-06-12 | Calpis Co., Ltd. | 炎症性腸疾患予防治療剤 |
KR100818360B1 (ko) | 2007-03-16 | 2008-04-02 | 건국대학교 산학협력단 | 신규 락토바실러스 플란타룸, 이의 생산을 위한 배지조성물및 이를 포함하는 조성물 |
CA2698190C (en) | 2007-08-29 | 2016-02-16 | Ganeden Biotech, Inc. | Baked goods |
WO2009051753A1 (en) * | 2007-10-16 | 2009-04-23 | Ganeden Biotech, Inc. | Beverage compositions |
KR100919892B1 (ko) * | 2007-12-27 | 2009-10-01 | 조선대학교산학협력단 | 메주로부터 분리된 바실러스 서브틸리스 및 이를 포함하는항균 조성물 |
EP2103226A1 (en) * | 2008-03-18 | 2009-09-23 | Friesland Brands B.V. | Long-life probiotic food product |
US8586029B2 (en) * | 2008-06-04 | 2013-11-19 | Trustees Of Dartmouth College | Prevention or treatment of immune-relevant disease by modification of microfloral populations |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
AU2009305668B2 (en) | 2008-10-16 | 2015-11-26 | Ganeden Biotech, Inc. | Probiotic grain-based compositions |
US8227235B2 (en) * | 2008-12-10 | 2012-07-24 | Alpharma, Llc | Compositions and methods for controlling diseases in animals |
AU2010242955B2 (en) | 2009-04-29 | 2016-02-04 | Ganeden Biotech, Inc. | Inactivated bacterial cell formulation |
US20100311686A1 (en) * | 2009-06-03 | 2010-12-09 | Kasper Lloyd H | Nutraceutical composition and methods for preventing or treating multiple sclerosis |
US8580278B2 (en) | 2009-06-03 | 2013-11-12 | Trustees Of Dartmouth College | Nutraceutical composition and methods for preventing or treating multiple sclerosis |
JP2011041500A (ja) * | 2009-08-20 | 2011-03-03 | Chiba Univ | 酵母Cyniclomycesguttulatusの分離・同定方法およびそれに用いるキット |
KR101138684B1 (ko) | 2010-02-08 | 2012-04-19 | 서범구 | 유용미생물 배양방법 및 이를 이용한 식품 |
CN103037877A (zh) * | 2010-03-12 | 2013-04-10 | 可尔必思株式会社 | 用于在大肠中增加双歧杆菌和抑制双歧杆菌减少的试剂 |
EP2593187A4 (en) | 2010-07-16 | 2014-04-09 | Univ Arkansas | METHODS AND COMPOSITIONS COMPRISING SPORTS-CREATING BACTERIA FOR ENHANCING ANIMAL HEALTH |
TWI401086B (zh) * | 2010-07-20 | 2013-07-11 | Univ China Medical | 胚芽乳酸桿菌及其用途 |
US9237763B2 (en) * | 2010-08-25 | 2016-01-19 | Tate & Lyle Ingredients Americas Llc | Synbiotic product |
ES2591356T3 (es) * | 2010-09-15 | 2016-11-28 | Investigación de Tecnologia Avanzada, S.A. de C.V. | Aislado de bacillus subtilis del maíz |
US9814242B2 (en) | 2010-09-15 | 2017-11-14 | Gruma S.A.B. De C.V. | Bacillus subtilis isolate from corn and extracts that inhibit the growth of undesirable microorganisms in food products |
WO2012044984A1 (en) | 2010-09-30 | 2012-04-05 | The Board Of Trustees Of The University Of Arkansas | Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads |
CN102653779B (zh) * | 2011-03-04 | 2014-02-19 | 北京科润三联生物技术有限责任公司 | 一种新型重组抗菌多肽药物的制备方法 |
US11235008B2 (en) | 2011-03-31 | 2022-02-01 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
US20120276056A1 (en) * | 2011-04-26 | 2012-11-01 | Wieslaw Janusz Bochenek | Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine |
US20120308490A1 (en) * | 2011-06-06 | 2012-12-06 | Abr Consulting S.R.L. | Method of obtaining a preparation of biological origin for oral hygiene to prevent the onset of tooth decay |
WO2013009945A1 (en) | 2011-07-12 | 2013-01-17 | The Brigham And Women's Hospital, Inc. | Lipid-containing psa compositions, methods of isolation and methods of use thereof |
AU2013246850B2 (en) | 2012-04-13 | 2018-03-29 | Chr. Hansen A/S | Antibiotic sensitive Bacillus strains having antimicrobial effect against E. coli and Clostridium perfringens and having high sporulation capacity |
WO2014022572A1 (en) | 2012-08-01 | 2014-02-06 | Pacific Vet Group-Usa, Inc. | Probiotic for amelioration of coccidiosis vaccine reaction |
GB201312713D0 (en) | 2013-03-22 | 2013-08-28 | Weaver Connie M | Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption |
US8734807B1 (en) * | 2013-04-06 | 2014-05-27 | Gabriel Langlois-Rahme | Preventing and curing Schistosomiasis mansoni by inhibiting Trk receptors on female Schistosoma |
FR3007655B1 (fr) * | 2013-06-28 | 2016-12-23 | Lesaffre & Cie | Souche bacillus subtilis pour le traitement et/ou la prevention de maladies inflammatoires chroniques |
CN103396969B (zh) * | 2013-08-19 | 2016-05-18 | 北京航天恒丰科技发展有限公司 | 侧孢短芽孢杆菌和枯草芽孢杆菌混合培养的发酵培养基及其发酵方法 |
CN104152516B (zh) * | 2014-08-29 | 2017-05-24 | 宁夏泰瑞制药股份有限公司 | 一种多粘类芽胞杆菌发酵生产粘杆菌素的培养基和补料方法 |
SG11201700006UA (en) * | 2014-08-29 | 2017-01-27 | Muhammed Majeed | Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof |
CN104726526B (zh) * | 2015-03-02 | 2017-12-19 | 广东海洋大学 | 一种利用鱼皮制备用于治疗伤口愈合的活性肽的方法 |
CA2997211A1 (en) | 2015-08-19 | 2017-02-23 | President And Fellows Of Harvard College | Lipidated psa compositions and methods |
EP3462917A4 (en) * | 2016-05-29 | 2020-01-08 | The State of Isreal, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) | PROCESS FOR PRODUCING BACTERIAL COMPOSITIONS |
WO2018014012A1 (en) | 2016-07-15 | 2018-01-18 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
KR102085787B1 (ko) * | 2016-08-12 | 2020-03-06 | 주식회사 엠디헬스케어 | 바실러스 속 세균 유래 나노소포 및 이의 용도 |
PE20200178A1 (es) | 2017-03-14 | 2020-01-24 | Chr Hansen As | Cepas de bacillus subtilis que mejoran los parametros de rendimiento en animales |
CN107198250B (zh) * | 2017-05-23 | 2019-03-12 | 北京瑞千景科技发展有限公司 | 改善肠道微生态预防慢性病组合物和均衡营养食品及应用 |
KR101934400B1 (ko) | 2017-07-12 | 2019-03-25 | 씨제이제일제당 주식회사 | 바실러스 서브틸리스 및 바실러스 리체니포미스를 포함하는 사료 첨가제, 상기 첨가제를 포함하는 사료 조성물 및 상기 사료첨가제의 제조 방법 |
CN107711137A (zh) * | 2017-10-20 | 2018-02-23 | 成都盛世光华生物科技有限公司 | 一种应用方式多样的合欢树营养液及其应用 |
WO2020072642A1 (en) * | 2018-10-02 | 2020-04-09 | Nutech Ventures | Novel gras probiotic bacterial strain to inhibit acidosis and liver abscesses in cattle |
WO2020090045A1 (ja) * | 2018-10-31 | 2020-05-07 | 株式会社村田製作所 | 抗グラム陰性菌化合物 |
CN109666601B (zh) * | 2018-12-03 | 2022-01-18 | 杭州娃哈哈科技有限公司 | 一株具有抑菌特性的植物乳杆菌及其在腹泻预防中的应用 |
BR112021018595A2 (pt) * | 2019-03-19 | 2021-11-23 | Microbial Discovery Group Llc | Cepas microbianas para inibição de vírus |
CN110144304B (zh) * | 2019-03-24 | 2021-08-27 | 广西大学 | 干酪乳杆菌菌株及其应用 |
BE1027162B1 (nl) * | 2019-03-29 | 2020-11-05 | My Res Comm V | Bacillus coagulans en Bacillus subtilis voor de preventie en behandeling van functionele gastro-intestinale stoornissen |
CA3135953A1 (en) * | 2019-04-02 | 2020-10-08 | National University Of Singapore | Engineered dysbiosis-sensing probiotic for clostridium difficile infections and recurring infections management |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
JP2023541829A (ja) * | 2020-09-07 | 2023-10-04 | イルドン ファーマスーティカル カンパニー リミテッド | バシラスサブティリス菌株及びこれの使用 |
CN114107134B (zh) * | 2021-12-22 | 2022-09-09 | 山东宝来利来生物工程股份有限公司 | 一株侧孢短芽孢杆菌及其应用 |
CN114806930B (zh) * | 2022-03-31 | 2022-11-22 | 青岛东海药业有限公司 | 一种益生菌组合物及其应用 |
CN115873748B (zh) * | 2022-08-18 | 2023-07-07 | 浙江省农业科学院 | 枯草芽孢杆菌、枯草芽孢杆菌发酵物及应用 |
CN116004464A (zh) * | 2023-01-06 | 2023-04-25 | 上海上药信谊药厂有限公司 | 一株植物乳杆菌及其应用 |
CN117180317B (zh) * | 2023-11-02 | 2024-01-26 | 深圳市第二人民医院(深圳市转化医学研究院) | 詹氏乳杆菌来源纳米囊泡在制备防治卵巢早衰治疗药物中的应用 |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2149240A (en) * | 1938-05-19 | 1939-02-28 | Calco Chemical Co Inc | Vaginal preparation |
US2330846A (en) * | 1939-05-01 | 1943-10-05 | Ortho Products Inc | Spermicide |
US2467884A (en) * | 1944-02-02 | 1949-04-19 | Nathaniel M Elias | Spermicides |
US2436184A (en) * | 1945-11-08 | 1948-02-17 | Eaton Lab Inc | Pharmaceutical jelly |
US2541103A (en) * | 1948-04-27 | 1951-02-13 | Ortho Pharma Corp | Spermicidal composition |
US2623839A (en) * | 1950-11-21 | 1952-12-30 | Schmid Inc Julius | Spermicidal compositions |
US2623841A (en) * | 1950-11-21 | 1952-12-30 | Schmid Inc Julius | Spermicidal compositions |
US3062715A (en) * | 1953-11-18 | 1962-11-06 | George S Pfaus | Vaginal tablet |
US3067743A (en) * | 1958-11-12 | 1962-12-11 | Alginate Ind Ltd | Alginic compounds |
US3108043A (en) * | 1960-05-09 | 1963-10-22 | Ortho Pharma Corp | Spermicidal sheet-like material |
US3174900A (en) * | 1962-10-10 | 1965-03-23 | Holland Rantos Company Inc | Thioether spermicidal method and composition |
US3244589A (en) * | 1962-10-26 | 1966-04-05 | Sunnen | Alkyl phenoxy polyethoxy ether spermicidal aerosol |
NL154600B (nl) * | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
NL154598B (nl) * | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
NL154599B (nl) * | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
US3901654A (en) * | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
US3853987A (en) * | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
US3867517A (en) * | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
NL171930C (nl) * | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
US3850578A (en) * | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
US3996345A (en) * | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4034074A (en) * | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
IT1039699B (it) * | 1975-07-03 | 1979-12-10 | Prephar | Composizione spermicida a base di derivati benzisotiazolici |
US3953074A (en) * | 1975-08-04 | 1976-04-27 | Herman E. Cox | Automatic and substantially permanent wheel balancing device |
US3984533A (en) * | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
US4098876A (en) * | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
FR2433949A1 (fr) * | 1978-08-25 | 1980-03-21 | Commissariat Energie Atomique | Substrat hydrophobe apte a liberer une substance chimique |
US4321277A (en) * | 1978-12-04 | 1982-03-23 | Research Lab Products, Inc. | Germicidal use of compositions containing certain quaternary ammonium compounds |
US4187286A (en) * | 1979-01-02 | 1980-02-05 | G&W Laboratories, Inc. | Contraceptive suppository |
IT1131833B (it) * | 1980-06-20 | 1986-06-25 | Crinos Industria Farmaco | Eccipienti per sostanze spermicide |
US4879219A (en) * | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
US4389330A (en) * | 1980-10-06 | 1983-06-21 | Stolle Research And Development Corporation | Microencapsulation process |
US4368186A (en) * | 1981-05-07 | 1983-01-11 | Syntex (U.S.A.) Inc. | Methods and compositions for intravaginal contraception |
US4415585A (en) * | 1982-03-11 | 1983-11-15 | University Of Illinois Foundation | Contraceptive method |
US4551148A (en) * | 1982-09-07 | 1985-11-05 | Kv Pharmaceutical Company | Vaginal delivery systems and their methods of preparation and use |
US5011771A (en) * | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
US4666828A (en) * | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4801531A (en) * | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
GB8812928D0 (en) * | 1988-06-01 | 1988-07-06 | Univ Manchester | Contraceptive methods & compositions |
US5227160A (en) * | 1988-07-15 | 1993-07-13 | The Biomembrane Institute | Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen |
US4999342A (en) * | 1988-08-16 | 1991-03-12 | Ortho Pharmaceutical Corporation | Long lasting contraceptive suppository composition and methods of use |
US5272057A (en) * | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
US5053339A (en) * | 1988-11-03 | 1991-10-01 | J P Labs Inc. | Color changing device for monitoring shelf-life of perishable products |
US5192659A (en) * | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
US5633835A (en) * | 1990-01-04 | 1997-05-27 | Temtec, Inc. | Long term rapid color changing time indicator |
US5446705A (en) * | 1991-02-04 | 1995-08-29 | Temtec, Inc. | Time indicator having discrete adhesive |
US5314917A (en) * | 1991-03-22 | 1994-05-24 | E. B. Michaels Research Associates, Inc. | Method for inactivating enveloped viruses and sperm |
DE4205400A1 (de) * | 1992-02-20 | 1993-08-26 | Markus Barainsky | Verbrauchsgegenstand |
US5229423A (en) * | 1992-03-06 | 1993-07-20 | Albert Einstein College Of Medicine Of Yeshiva University | Use of butylurea as a contraceptive agent |
US5667817A (en) * | 1992-03-20 | 1997-09-16 | Alcide Corporation | Method and composition for prevention and treatment of female lower genital tract microbial infections |
US5281521A (en) * | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
US5380523A (en) * | 1993-08-17 | 1995-01-10 | University Of Kentucky Research Foundation | High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties |
US5795602A (en) * | 1996-04-12 | 1998-08-18 | Cargill, Incorporated | Milk enhancer and milk feed composition |
US6410305B1 (en) * | 1997-08-04 | 2002-06-25 | Biosun Systems Corporation | Treatment of animal waste |
US6448224B1 (en) * | 1998-05-06 | 2002-09-10 | St. Jude Children's Research Hospital | Antibiotics and methods of using the same |
US6156355A (en) * | 1998-11-02 | 2000-12-05 | Star-Kist Foods, Inc. | Breed-specific canine food formulations |
IL130303A0 (en) * | 1999-06-03 | 2000-06-01 | M G Novobiotech Ltd | A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use |
JP4592885B2 (ja) * | 2000-07-31 | 2010-12-08 | 富士通セミコンダクター株式会社 | 半導体基板試験装置 |
PE20030283A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de lactobacillus casei |
-
2004
- 2004-08-12 MX MXPA06001722A patent/MXPA06001722A/es not_active Application Discontinuation
- 2004-08-12 CA CA002535951A patent/CA2535951A1/en not_active Abandoned
- 2004-08-12 RU RU2006107931/13A patent/RU2006107931A/ru not_active Application Discontinuation
- 2004-08-12 JP JP2006523213A patent/JP2007518394A/ja active Pending
- 2004-08-12 WO PCT/US2004/024372 patent/WO2005019417A2/en active Search and Examination
- 2004-08-12 KR KR1020067003075A patent/KR20060056991A/ko not_active Application Discontinuation
- 2004-08-12 EP EP04779435A patent/EP1654348A4/en not_active Withdrawn
- 2004-08-12 BR BRPI0412978-4A patent/BRPI0412978A/pt not_active Application Discontinuation
- 2004-08-12 US US10/916,646 patent/US20050271643A1/en not_active Abandoned
- 2004-08-12 CN CNA2004800301677A patent/CN101076585A/zh active Pending
- 2004-08-12 AU AU2004267383A patent/AU2004267383A1/en not_active Abandoned
-
2006
- 2006-02-13 ZA ZA200601265A patent/ZA200601265B/en unknown
- 2006-02-13 IL IL173692A patent/IL173692A0/en unknown
- 2006-03-10 IN IN859CH2006 patent/IN2006CH00859A/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2006107931A (ru) | 2006-07-27 |
MXPA06001722A (es) | 2006-05-19 |
AU2004267383A1 (en) | 2005-03-03 |
BRPI0412978A (pt) | 2006-10-03 |
EP1654348A4 (en) | 2008-02-13 |
EP1654348A2 (en) | 2006-05-10 |
US20050271643A1 (en) | 2005-12-08 |
WO2005019417A3 (en) | 2007-07-26 |
KR20060056991A (ko) | 2006-05-25 |
ZA200601265B (en) | 2007-06-27 |
IL173692A0 (en) | 2006-07-05 |
JP2007518394A (ja) | 2007-07-12 |
CA2535951A1 (en) | 2005-03-03 |
WO2005019417A2 (en) | 2005-03-03 |
CN101076585A (zh) | 2007-11-21 |